Palmoplantar pustulosis
PPP · Immunology · 1 drugs · 1 indications
Competitive Landscape (1 drugs)
| Drug | Company | Mechanism | Modality | Route | Stage |
|---|
| Bimzelx | UCB | IL-17A/F inhibitor | Antibody | SC | APPROVED |
Indications (1)
Upcoming Catalysts
Bimzelx - Commercial Momentum UpdatesCOMMERCIAL
UCB2026
Bimzelx vs Risankizumab - PsA - Head-to-Head DataCLINICAL
UCBH2 2026
Data from Supabase · Updated 2026-03-24